Services search (in the department)
| Illness | Number of cases |
|---|---|
| Hyperplasia of prostate (N40) | 124 |
| Cystitis (N30.2) | 83 |
| Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9) | 41 |
| Malignant neoplasm of prostate (C61) | 27 |
| Benign neoplasm of urinary organs - Benign neoplasm of bladder (D30.3) | 17 |
| Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | 10 |
| Malignant neoplasm of ureter (C66) | not specified |
| Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) | not specified |
| Malignant neoplasm of bladder - Malignant neoplasm of bladder neck (C67.5) | not specified |
| Benign neoplasm of male genital organs - Benign neoplasm of prostate (D29.1) | not specified |
| Treatment | Number |
|---|---|
| Injection or administration of medicines into the urinary bladder (8-132.3) | 322 |
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 156 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.70) | 96 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) | 41 |
| Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1) | 38 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 29 |
| X-rays of the kidney and urinary tract with contrast medium (3-13d.5) | 26 |
| Insertion, exchange or removal of a ureteral stent (8-137.00) | 19 |
| Removal of stones, foreign bodies or collections of blood from the bladder by endoscopy (5-570.0) | 15 |
| Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) | 14 |
| Number | Group |
|---|---|
| 26 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 5 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 5 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Participation in multi-centre phase III/IV studies | |
| Project-related cooperation with colleges and universities | |
| Student training (clinical traineeship / internship year) |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB19 | Nursing professionals | (ehemals Gesundheits- und Krankenpfleger) |
| HB17 | Auxiliary nurse (m/f) | |
| HB03 | Physical therapist / physiotherapist (m/f) | in Kooperation Praxiseinsätze im Krankenhaus |
| HB18 | Emergency paramedics (m/f) (training period 3 years) | In Kooperation/Praxiseinsätze im Krankenhaus |
Dr. Ralph Tölg
Ärztlicher Direktor, Chefarzt Innere Medizin / Kardiologie
Phone:
--
Mail:
moc.soipelksa@gleot.r